comprehensive -WSS

comprehensive

author：comprehensive 2025-09-27 21:27:42 - browse：8

The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology, a groundbreaking treatment for sickle cell disease that delivers a potential cure for people born with the chronic and life-shortening blood disorder.

The new medicine, called Casgevy, is made by Vertex Pharmaceuticals and CRISPR Therapeutics. Its authorization is a scientific triumph for the technology that can efficiently and precisely repair DNA mutations — ushering in a new era of genetic medicines for inherited diseases.

In a clinical trial, Casgevy was shown to eliminate recurrent episodes of debilitating pain caused by sickle cell, which afflicts approximately 100,000 people in the U.S., a vast majority of whom are Black. The therapy, whose scientific name is exa-cel, is described as a potential cure because the genetic fix enabled by CRISPR is designed to last a lifetime, although confirmation will require years of follow-up.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： ALS patient reclaims some autonomy thanks to wearable 'robot'

WSS

Diabetes management: Digital health tools fall short, study says

Cheap, fast test for Zika and dengue could cost just $1

Health care court cases: Humana, Sutter, Novant

Study: Why relieving medical debt did not improve financial outcomes

Erich Jarvis studies song birds to learn about human stuttering

CRISPR technology availability, affordability needs to be expanded

Wikipedia

comprehensive

focus

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Texas board proposes rules on abortion law emergency exemption

Affirmative action in medical school literally saved lives

Medicare Advantage insurers pressure Biden for bigger payments

Activists slam private health insurers over coverage restrictions

Yancopoulos of Regeneron works to expand Dupixent success

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

New report analyzes digital physical therapy solutions' effectiveness

Sports medicine is finally prioritizing gender equality

CRISPR technology availability, affordability needs to be expanded

focus

Statins may not be needed by millions of people, study suggests

Asbestos ban is immediate, but health effects will linger for decades

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Diabetes management: Digital health tools fall short, study says

Medicare Advantage insurers pressure Biden for bigger payments

Wikipedia

hotspot

hotspot

Wikipedia